Publication | Closed Access
Tissue-resident memory CD8 <sup>+</sup> T cells cooperate with CD4 <sup>+</sup> T cells to drive compartmentalized immunopathology in the CNS
58
Citations
73
References
2022
Year
In chronic inflammatory diseases of the central nervous system (CNS), immune cells persisting behind the blood-brain barrier are supposed to promulgate local tissue destruction. The drivers of such compartmentalized inflammation remain unclear, but tissue-resident memory T cells (T<sub>RM</sub>) represent a potentially important cellular player in this process. Here, we investigated whether resting CD8<sup>+</sup> T<sub>RM</sub> persisting after cleared infection with attenuated lymphocytic choriomeningitis virus (LCMV) can initiate immune responses directed against cognate self-antigen in the CNS. We demonstrated that time-delayed conditional expression of the LCMV glycoprotein as neo-self-antigen by glia cells reactivated CD8<sup>+</sup> T<sub>RM</sub>. Subsequently, CD8<sup>+</sup> T<sub>RM</sub> expanded and initiated CNS inflammation and immunopathology in an organ-autonomous manner independently of circulating CD8<sup>+</sup> T cells. However, in the absence of CD4<sup>+</sup> T cells, TCF-1<sup>+</sup> CD8<sup>+</sup> T<sub>RM</sub> failed to expand and differentiate into terminal effectors. Similarly, in human demyelinating CNS autoimmune lesions, we found CD8<sup>+</sup> T cells expressing TCF-1 that predominantly exhibited a T<sub>RM</sub>-like phenotype. Together, our study provides evidence for CD8<sup>+</sup> T<sub>RM</sub>-driven CNS immunopathology and sheds light on why inflammatory processes may evade current immunomodulatory treatments in chronic autoimmune CNS conditions.
| Year | Citations | |
|---|---|---|
Page 1
Page 1